English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Plus annual

Presents the access of premium content as premium feature

Premium Content

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Tools annual

Global: Zendy Free Plan

Global: Zendy Tools monthly

Global: Zendy Plus monthly

We aimed to explore the therapeutic effect of  Bifidobacterium lactis  on food allergy by investigating the percentage of Treg and Th17 cells in Chinese children and related molecular mechanisms. A total of 256 children with food allergy were evenly assigned into two groups: BG, the children received 10 ml  B. lactis  (1 × 10 6 /ml) daily, and CG, the children received the solution without  B. lactis  daily for three months. Allergic symptoms, serum IgE, and food antigen-specific IgE were measured. A mouse allergy model was established by using shrimp tropomyosin and treated with  B. lactis . Relative mRNA levels of Treg- and Th17-associated cytokines were measured by using quantitative PCR. The percentage of Treg and Th17 cells in spleen were measured by using flow cytometry. After 3-month therapy, the allergic symptoms of the BG were remarkably reduced when compared with the CG ( P  < 0.05). Serum levels of IgE and food antigen-specific IgE were decreased too ( P  < 0.05). Similar results were also found in a mouse allergy model. After  B. lactis  treatment, the relative mRNA level of FoxP3 was significantly enhanced in the  B. lactis  therapy group when compared to positive controls. In addition, relative mRNA levels of FoxP3 and TGF- β  associated with Treg cells were increased, whereas relative mRNA levels of IL-17A and IL-23 associated with Th17 were reduced.  B. lactis  treatment significantly increased the ratio of Treg and Th17 cells in a mouse allergy model ( P  < 0.05).  B. lactis  effectively alleviates allergic symptoms by increasing the ratio of Treg and Th17 cells.

Bifidobacterium lactisAmeliorates the Risk of Food Allergy in Chinese Children by Affecting Relative Percentage of Treg and Th17 Cells